Education
About Us
Working with TipRanks
Follow Us
Balchem Corp. (BCPC)
NASDAQ:BCPC
BCPC Stock Chart & Stats
$156.30
$0.69(0.44%)
At close: 4:00 PM EST
$156.30
$0.69(0.44%)
Day’s Range― - ―
52-Week Range$139.17 - $177.40
Previous CloseN/A
Volume32.16K
Average Volume (3M)199.55K
Market Cap
$5.06B
Enterprise Value$5.00B
Total Cash (Recent Filing)$65.09M
Total Debt (Recent Filing)$155.80M
Price to Earnings (P/E)34.2
Beta0.54
Next Earnings
Feb 13, 2026EPS Estimate
1.18Next Dividend Ex-DateN/A
Dividend Yield0.56%
Share Statistics
EPS (TTM)1.24
Shares Outstanding32,386,260
10 Day Avg. Volume295,651
30 Day Avg. Volume199,550
Financial Highlights & Ratios
PEG Ratio2.35
Price to Book (P/B)4.58
Price to Sales (P/S)5.53
P/FCF Ratio36.01
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue4.93
Enterprise Value/Gross Profit13.77
Enterprise Value/Ebitda19.22
Forecast
1Y Price Target
$176.00Price Target Upside12.60% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)4.79
Revenue Forecast (FY)$1.03B
Bulls Say, Bears Say
Bulls Say
Capacity ExpansionThe construction of a new state-of-the-art facility is expected to more than double Balchem’s capacity for its fast-growing micro-encapsulation technologies.
EarningsBalchem's revenue and earnings beat expectations, driven by strong sales performance and operational efficiency.
Future Growth PotentialThe Human Nutrition and Health segment significantly outperformed expectations, indicating robust future growth potential.
Bears Say
Balchem News
BCPC FAQ
What was Balchem Corp.’s price range in the past 12 months?
Balchem Corp. lowest stock price was $139.17 and its highest was $177.40 in the past 12 months.
What is Balchem Corp.’s market cap?
Balchem Corp.’s market cap is $5.06B.
When is Balchem Corp.’s upcoming earnings report date?
Balchem Corp.’s upcoming earnings report date is Feb 13, 2026 which is in 53 days.
How were Balchem Corp.’s earnings last quarter?
Balchem Corp. released its earnings results on Oct 21, 2025. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.155 by $0.085.
Is Balchem Corp. overvalued?
According to Wall Street analysts Balchem Corp.’s price is currently Undervalued.
Does Balchem Corp. pay dividends?
Balchem Corp. pays a Annually dividend of $0.87 which represents an annual dividend yield of 0.56%. See more information on Balchem Corp. dividends here
What is Balchem Corp.’s EPS estimate?
Balchem Corp.’s EPS estimate is 1.18.
How many shares outstanding does Balchem Corp. have?
Balchem Corp. has 32,386,260 shares outstanding.
What happened to Balchem Corp.’s price movement after its last earnings report?
Balchem Corp. reported an EPS of $1.24 in its last earnings report, beating expectations of $1.155. Following the earnings report the stock price went up 4.059%.
Which hedge fund is a major shareholder of Balchem Corp.?
Currently, no hedge funds are holding shares in BCPC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Balchem Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$176.00 (12.60% Upside)
$176.00 (12.60% Upside)
Blogger Sentiment
Bullish
BCPC Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 17.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ―
Last 30 Days ―
Last 30 Days ―
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.64%
12-Months-Change
Fundamentals
Return on Equity
12.06%
Trailing 12-Months
Asset Growth
4.01%
Trailing 12-Months
Company Description
Balchem Corp.
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
BCPC Company Deck
BCPC Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance for Balchem Corporation, with record-breaking revenue and growth across all segments. Despite challenges such as increased operating expenses and complex international trade issues, the company continues to demonstrate resilience and strategic growth, particularly in the Human Nutrition and Health and Specialty Products segments.View all BCPC earnings summariesBCPC Stock 12 Month Forecast
Average Price Target
$176.00
▲(12.60% Upside)
Technical Analysis
Ownership Overview
0.58% Insiders
30.12% Mutual Funds
23.94% Other Institutional Investors
19.40% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---